SCHEMBL8320004

SCHEMBL8320004

COc1ccccc1OC(=O)C1CCC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.63
NPC1 O15118 2/20 0.55
KMT2A Q03164 4/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
HTT P42858 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.53
MEN1 O00255 2/20 0.53
RAB9A P51151 2/20 0.53
HPGD P15428 5/20 0.52
ESR1 P03372 1/20 0.51
ESR2 Q92731 1/20 0.51
ALDH1A1 P00352 2/20 0.50
ELANE P08246 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA4 P22748 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31321646 0.95 POLB (0.62) POLBNPC1KMT2ASMN1; SMN2HTT
SCHEMBL4123709 0.93 POLB (0.67) POLBNPC1KMT2ASMN1; SMN2HTT
SCHEMBL16756229 0.91 KMT2A (0.64) POLBNPC1KMT2ASMN1; SMN2HTT
SCHEMBL16756223 0.87 ESR1 (0.63) POLBNPC1KMT2ASMN1; SMN2HTT
SCHEMBL28731538 0.86 POLB (0.58) POLBNPC1KMT2ASMN1; SMN2HTT
SCHEMBL16756220 0.85 ESR1 (0.66) POLBKMT2ASMN1; SMN2HTTTDP1
SCHEMBL10571601 0.85 ESR1 (0.66) POLBKMT2ASMN1; SMN2HTTTDP1
SCHEMBL16756210 0.85 ESR1 (0.66) POLBKMT2ASMN1; SMN2HTTTDP1
SCHEMBL16756212 0.83 L3MBTL1 (0.70) POLBNPC1KMT2ASMN1; SMN2HTT
SCHEMBL8319368 0.83 PPARG (0.55) POLBKMT2ASMN1; SMN2HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116615193-A Tumoxic acid monoester derivative as selective FABP5 inhibitor, pharmaceutical composition and application thereof 纽约州立大学研究基金会 2023-08-18 CN disclosed
EP-0923536-A1 ARYLCYCLOALKANE CARBOXYLIC ESTERS, THEIR USE, PHARMACEUTICAL COMPOSITIONS AND PREPARATION Pharmacia & Upjohn Aktiebolag (SE) 1999-06-23 EP disclosed
WO-1998004517-A1 ARYLCYCLOALKANE CARBOXYLIC ESTERS, THEIR USE, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PHARMACIA & UPJOHN AB (SE) 1998-02-05 WO disclosed